Today FDA released an announcement that Zimmer Biomet is recalling its Comprehensive Reverse Shoulder due to a high fracture rate. This device issue can lead to adverse events, including permanent…
Today FDA released an announcement that Zimmer Biomet is recalling its Comprehensive Reverse Shoulder due to a high fracture rate. This device issue can lead to adverse events, including permanent…
…the U.S. medtech industry lost 28,834 jobs—a 7.2% decrease. The majority of job losses were seen in 2014, with the industry losing about 27,000 positions in the industry. https://medtechintelligence.com/news_article/trumps-impact-pricing-rd-funding-cybersecurity-among-top-trends-new-year/…
…the U.S. medtech industry lost 28,834 jobs—a 7.2% decrease. The majority of job losses were seen in 2014, with the industry losing about 27,000 positions in the industry. https://medtechintelligence.com/news_article/trumps-impact-pricing-rd-funding-cybersecurity-among-top-trends-new-year/…
…marketing and sales. This company wanted us to work with the local government executives to maximize benefits and incentives that foreign device company could possibly get for their new operations…
…marketing and sales. This company wanted us to work with the local government executives to maximize benefits and incentives that foreign device company could possibly get for their new operations…
…widespread in the standards community, and certainly, there are many types of risk. However, the different risks being considered and addressed by various stakeholders can create regulatory problems if it…
…widespread in the standards community, and certainly, there are many types of risk. However, the different risks being considered and addressed by various stakeholders can create regulatory problems if it…
Today Allergan announced its intention to acquire California-based medical aesthetics company Zeltiq Aesthetics, Inc. Zeltiq manufactures products that use its patented cooling technology, most notably the CoolSculpting System, which is…
Today Allergan announced its intention to acquire California-based medical aesthetics company Zeltiq Aesthetics, Inc. Zeltiq manufactures products that use its patented cooling technology, most notably the CoolSculpting System, which is…
…Devine guidance for managing key attributes of a FDA-compliant quality management system – 21 CFR, Part 820 Compliance. Charleston, SC: Amazon. FDA. (January 2017). Inspections, Compliance, Enforcement, and Criminal Investigations….
…Devine guidance for managing key attributes of a FDA-compliant quality management system – 21 CFR, Part 820 Compliance. Charleston, SC: Amazon. FDA. (January 2017). Inspections, Compliance, Enforcement, and Criminal Investigations….
…the fundamental considerations during remediation. MedTech Intelligence: What key points should device companies consider during remediation? Mark Leimbeck: Infrastructure If your company needs to generate information for legacy devices, you…
…the fundamental considerations during remediation. MedTech Intelligence: What key points should device companies consider during remediation? Mark Leimbeck: Infrastructure If your company needs to generate information for legacy devices, you…
Breast cancer is the most commonly diagnosed type of cancer and the second leading cause of death among women, as evident from stats revealed by the National Breast Cancer Foundation….
Breast cancer is the most commonly diagnosed type of cancer and the second leading cause of death among women, as evident from stats revealed by the National Breast Cancer Foundation….
…(2013). Devine guidance for managing key attributes of a FDA-compliant quality management system – 21 CFR, Part 820 Compliance. Charleston, SC: Amazon. FDA. (July 2016). Inspections, Compliance, Enforcement, and Criminal…
…(2013). Devine guidance for managing key attributes of a FDA-compliant quality management system – 21 CFR, Part 820 Compliance. Charleston, SC: Amazon. FDA. (July 2016). Inspections, Compliance, Enforcement, and Criminal…
…is providing the first commercial noninvasive solution for this approach with the CardioInsight Noninvasive 3D Mapping System. The technology received 510(k) approval from FDA and can be used to map…
…is providing the first commercial noninvasive solution for this approach with the CardioInsight Noninvasive 3D Mapping System. The technology received 510(k) approval from FDA and can be used to map…
